Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease?

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 1, 2003, Pages 107-111

  Chan, Vivian ^a   Wong, Man Sim ^a   Ooi, Clara ^a   Chen, F E ^a   Chim, C S ^a   Liang, R H S ^a   Todd, D ^a   Chan, T K ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

HbH disease; HFE gene; Iron overload; TFR2 gene

Indexed keywords

FERRITIN; HEMOGLOBIN H; RECEPTOR SUBTYPE; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; INTRON; IRON ABSORPTION; IRON OVERLOAD; IRON TRANSPORT; MALE; MISSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0037232545     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00013-5     Document Type: Article

References (19)

1. Chan V., Chan T.K., Cheng M.Y., Kan Y.W., Todd D. Organization of ζ-α genes in the Chinese. Br. J. Hematol. 64:1986;97-105.
2. Fucharoen, S., Wasi, P. Thalassaemia in Southeast Asia, in: Program and abstracts of the 2nd International Conference on Thalassemia in China: Thalassemia in Millenium, Nanning, Guangxi, China, October 13-16, 1998, pp. 3-4 (abstract).
3. Chen F.E., Ooi C., Ha S.Y., Cheung B.M.Y., Todd D., Liang R., Chan T.K., Chan V. Genetic and clinical features of hemoglobin H disease in Chinese patients. N. Engl. J. Med. 343:2000;544-550.
4. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo R. Jr., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., McClelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Prass C.E., Quintana L., Starnes S.M., Schatzman R.C., Brunke K.J., Drayana D.T., Risch N.J., Bacon B.R., Wolff R.K. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:1996;399-408.
5. Mura C., Nousbaum J.B., Verger P., Moalic M.T., Raguenes O., Mercier A.Y., Ferec C. Phenotype-genotype correlation in haemochromatosis subjects. Hum. Genet. 101:1997;271-276.
6. Fleming R.E., Migas M.C., Holden C.C., Waheed A., Britton R.S., Tomatsu S., Bacon B.R., Sly W.S. Transferrin receptor 2 continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis . Proc. Natl. Acad. Sci. USA. 97:2000;2214-2219.
7. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., Majorano N., Totaro A., Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25:2000;14-15.
8. Jazwinska E.C., Cullen L.M., Busfield F., Pyper W.R., Webb S.I., Powell L.W., Morris C.P., Walsh T.P. Haemochromatosis and HLA-H. Nat. Genet. 14:1996;249-251.
9. Mura C., Raguenes O., Ferec C. HFE mutation analysis in 711 hemochromatosis probands evidence for S65C implication in mild form of hemochromatosis . Blood. 93:1999;2502-2505.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Ooi G.C., Chen F.E., Chan K.N., Tsang K.W.T., Wong Y.H., Liang R., Chan V., Ngan H. Qualitative and quantitative magnetic resonance imaging in haemoglobin H disease screening for iron overload . Clin. Radiol. 54:1999;98-102.
12. Kreeftenberg H.G. Jr., Mooyaart E.L., Huizenga J.R., Sluiter W.J. Quantification of liver iron concentration with magnetic resonance imaging by combining T1-, T2-weighted spin echo sequences and a gradient echo sequence. Neth. J. Med. 56:2000;133-137.
13. Scerri C.A., Abela W., Galdies R., Pizzuto M., Grech J.L., Felice A.E. The β+ IVS1-nt no. 6 (T→C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta. Br. J. Hematol. 83:1993;669-671.
14. Lee P.L., Halloran C., West C., Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol. Dis. 27:2001;285-289.
15. Chou P.Y., Fassman G.D. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47:1978;45-148.
16. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., Robson K.J.H. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34:1997;275-278.
17. Cullen L.M., Gao X., Easteal S., Jazwinska E.C. The hemochromatosis 845 G→A and 187 C→G mutations prevalence in non-Caucasian populations . Am. J. Hum. Genet. 62:1998;1403-1407.
18. Roetto A., Totaro A., Piperno A., Piga A., Longo F., Garozzo G., Cali A., De Gobbi M., Gasparini P., Camaschella C. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood. 97:2001;2555-2560.
19. Barton E.H., West P.A., Rivers C.A., Barton J.C., Acton R.T. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload. Blood Cells Mol. Dis. 27:2001;279-284.